Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preoperative Rocaltrol before parathyroidectomy to prevent postoperative hypocalcemia
IRCT20220822055773N2Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Sep 2016
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of calcitriol in primary hyperparathyroidism (PHPT) (2 arms), sponsored by Tehran University of Medical Sciences. Primary endpoints: Postoperative hypocalcemia prevention and Serum calcium after operation. Started Sep 2016; status: completed.
02
Drugs
calcitriol
03
Conditions
primary hyperparathyroidism (PHPT)
Beyond the preview
Go deeper on IRCT20220822055773N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20220822055773N2.